The Annual General Meeting of Nobel Biocare approves all proposals of the Board of Directors

Nobel Biocare Holding AG's Annual General Meeting today endorsed all proposals put forward by the Board of Directors.

Among others, the Annual General Meeting approved a dividend of CHF 0.20 gross per registered share of CHF 0.40 nominal value. The dividend will be paid on 8 April 2013 (ex-dividend day: 3 April 2013; record date: 5 April 2013) in a shareholder-friendly way without deduction of withholding tax.

All Board members proposed for re-election were re-elected: Daniela Bosshardt-Hengartner, Raymund Breu, Edgar Fluri, Michel Orsinger, Juha Raisanen, Oern Stuge, Rolf Watter and Georg Watzek.

Franz Maier was elected as a new Board member.

According to the by-laws, all Board members have been elected for a one-year term.

At the first board meeting following the Annual General Meeting, Rolf Watter was re-elected Chairman of the Board and Raymund Breu was re-elected Vice-Chairman of the Board. The Board committees will be chaired by Oern Stuge (Innovation and Technology), Edgar Fluri (Audit), Juha Raisanen (Operations and Process Excellence), Rolf Watter (Nomination and Compensation) and Michel Orsinger (Strategy (newly established committee)).

KPMG, Zurich, has been re-elected as auditors for the financial year 2013.

The next Annual General Meeting of the shareholders will be convened on March 26, 2014.